Prescription Required
Glykind-M Tablet 10s is a combination medication used in the management of type 2 diabetes. This formulation contains two active ingredients: Gliclazide (a sulfonylurea) and Metformin (a biguanide). Glykind-M helps to control blood sugar levels by improving insulin sensitivity and stimulating the pancreas to release insulin. It is primarily used for patients who cannot achieve adequate control with diet and exercise alone.
Glykind-M Tablet offers an effective, convenient way for individuals with type 2 diabetes to manage their condition, preventing the long-term complications of uncontrolled blood sugar levels such as cardiovascular issues, kidney damage, and nerve problems.
Alcohol consumption should be limited while taking Glykind-M, as it can cause a dangerous drop in blood sugar levels (hypoglycemia) or increase the risk of side effects. Always consult your doctor about alcohol use during treatment.
Patients with liver disease should use Glykind-M with caution, as both components can affect liver function. Close monitoring is recommended if you have liver issues.
Glykind-M should be used with caution in patients with kidney problems. Metformin can accumulate in the body and cause lactic acidosis in individuals with impaired kidney function. If you have a history of kidney disease, consult your doctor before using this medication.
Glykind-M is not recommended during pregnancy unless clearly necessary. It is essential to consult your doctor if you are pregnant or planning to become pregnant. Managing blood sugar is critical during pregnancy, and your healthcare provider may suggest an alternative treatment.
Glykind-M is not recommended during breastfeeding. Both Gliclazide and Metformin pass into breast milk, and it’s important to discuss safer treatment options with your doctor if you are breastfeeding.
Gliclazide can cause hypoglycemia (low blood sugar), which may impair your ability to concentrate and react. Avoid driving or operating machinery if you experience symptoms of low blood sugar (such as dizziness, weakness, or confusion).
Glykind-M Tablet combines **Gliclazide** and **Metformin** to effectively manage type 2 diabetes. **Gliclazide**, a sulfonylurea, stimulates the pancreas to produce more insulin, helping lower blood sugar levels after meals. **Metformin**, a biguanide, enhances insulin sensitivity in muscle and fat cells, reduces sugar production in the liver, and slows glucose absorption from the intestines. Together, these medications target multiple pathways to regulate blood sugar levels, reducing the risk of diabetes-related complications like heart disease, kidney damage, and nerve issues.
Type 2 diabetes is a chronic condition characterized by high blood sugar levels due to the body's inability to use insulin effectively.
Store Glykind-M Tablet at room temperature, away from moisture and direct sunlight. Keep out of reach of children.
Glykind-M Tablet 10s is an effective medication for managing type 2 diabetes. Combining Gliclazide and Metformin, this medication works to control blood sugar levels by improving insulin sensitivity and stimulating insulin production. It provides comprehensive management of diabetes, helping to prevent complications such as cardiovascular disease and kidney damage.
Content Updated on
Wednesday, 5 March, 2025Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA